Navigation Links
UM Clinical Research Building awarded prestigious LEED Building Certification
Date:12/1/2009

MIAMI, FL (December 1, 2009)The Clinical Research Building (CRB), at the University of Miami Miller School of Medicine, has been honored for its sustainability components. The building was awarded the LEED designation, established by the U.S. Green Building Council and verified by the Green Building Certification Institute (GBCI). LEED is the nation's preeminent program for the design, construction and operation of green buildings.

"Having a LEED certified building means we're doing our part as a University to be environmentally and socially responsible," says Juan C. Endara, project manager of UM Facilities, Design and Construction. "The LEED certification of the building recognizes those efforts."

The Clinical Research Building on the medical campus achieved LEED certification specifically for its energy use, water and material use, as well as incorporating a variety of other sustainable strategies. By using less energy and water, LEED certified buildings save money for families, businesses and taxpayers; reduce greenhouse gas emissions; and contribute to a healthier environment for residents, workers and the larger community.

"The building meets a high level of performance standards, provides a healthier work environment for the employees and occupants, and costs less to operate and maintain than a non-certified building," Endara says.

LEED Certification of the UM CRB was based on a number of green design and construction features that positively impact the project itself and the broader community. These features include:

  • Use of drought tolerant native shrubs and planting materials resulting in 53 percent reduction of irrigating water consumption.
  • Use of plumbing fixtures that reduce the use of potable water consumption by 30 percent
  • Providing 78 percent of the building's electricity with renewable sources (green power)
  • Use of carpet tiles made with recycled materials and use of adhesives with low emitting gases content
  • An HVAC (heating, ventilating and air conditioning system) designed to conserve energy
  • Implementation of a Green-Cleaning Housekeeping Program

The main purpose of the CRB is to support the continued growth of the UM Miller School of Medicine's clinical research programs and to consolidate current clinical research programs into a single facility. The 15 story, 336,000 square-foot building sits adjacent to SR 836 and I-95, at 1120 NW 14th Street. Its design and construction is consistent with the University of Miami's Green U initiative to become more sustainable through the procurement of environmentally responsible products and environmentally sound maintenance and operations procedures for existing and new buildings.


'/>"/>

Contact: Marie Guma-Diaz
m.gumadiaz@umiami.edu
305-284-5500
University of Miami
Source:Eurekalert  

Related medicine news :

1. OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent
2. Elsevier Launches New Online ARRA Resource Center and Clinical Decision Support Blog
3. Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines
4. Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via
5. Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store
6. Baylor Sammons Cancer Center Joins One of Nations Largest Cancer Clinical Trials Groups
7. Circassia Announces Successful Results From Phase II Clinical Study of ToleroMune(R) Cat Allergy Therapy
8. Albireo Announces Positive Clinical Data on A3309 in Patients with Chronic Idiopathic Constipation
9. Tulane Cancer Center to begin novel clinical trial for late-stage prostate cancer drug
10. Ziosoft Will Showcase New Clinical Functionality and Workflow Optimization Tools for Its Advanced 3D Thin-Client Software at RSNA 2009
11. American Heart Association Late Breaking Clinical Trial Report: In Patients on Statins, Raising Good Cholesterol with Niacin, but not Reducing Bad Cholesterol with Ezetimibe, Decreases Plaque Build-Up
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
UM Clinical Research Building awarded prestigious LEED Building Certification
(Date:3/28/2017)... ... ... Silicon Valley Hair Institute, the San Francisco Bay Area leader in women's ... loss. Although hair transplant procedures can be seen as more of a man’s issue, ... two reasons a woman may see her hair thinning. , “We are used to ...
(Date:3/28/2017)... ... March 28, 2017 , ... Bacteria and fungi are probably not the first ingredients that come ... including the right microorganisms in your diet can actually improve health outcomes. And the good ... is the topic of a new peer-reviewed paper led by Maria Marco, ...
(Date:3/27/2017)... ... March 27, 2017 , ... Drs. Justin Kolnick, Kara Diamond, ... teaching their patients about the key role this treatment plays in protecting oral health, ... endodontist. To better serve those who need a root canal in White Plains, NY ...
(Date:3/27/2017)... ... 27, 2017 , ... Buzzies parent company, The TouchPoint Solution’s CEO and co-founder, ... and UBS’ Project Entrepreneur. Mayo will present her pitch about the lifestyle wearable devices, ... second annual venture competition ignites bold ideas by providing women access to the tools, ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... athletes. A type of groin injury, it occurs when the muscles around the ... pain in and around the lower torso, as well as accompanying tenderness and ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... 2017 On Friday, benchmark US ... closed the trading session up 0.19%; the Dow Jones ... was down 0.08%. US markets made broad based gains ... in green. Pre-market today, Stock-Callers.com reviews these four Medical ... WMGI), Amedica Corporation (NASDAQ: AMDA), MiMedx Group Inc. (NASDAQ: ...
(Date:3/27/2017)... , March 27, 2017  Impax Laboratories, Inc. (NASDAQ: ... Paul M. Bisaro as Impax,s President and ... Board, effective March 27, 2017. Mr. Bisaro will succeed ... Interim President and Chief Executive Officer since December of ... and branded pharmaceutical experience, Mr. Bisaro, 56, is an ...
(Date:3/27/2017)... , March 27, 2017 Arena Pharmaceuticals, Inc. ... on developing novel, small molecule drugs across multiple therapeutic areas, ... Chief Executive Officer, will present a corporate update at the ... 3:40pm ET.  The conference will take place April 4-5, 2017 ... New York , NY.  A live ...
Breaking Medicine Technology: